CORI Quote Trading Chart Corium International Inc.

$ Last:

0.24% Change Percent:

$12.67 Open:

$12.68 Previous Close:

$12.745 High:

$12.65 Low:

4,072,230 Volume:

12/31/1969 07:00:00 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Stock Date	Open Price	Close Price	High	Low	Volume
2018-11-26	12.67	12.68	12.745	12.65	4,072,230
2018-11-23	12.66	12.65	12.68	12.64	598,882
2018-11-21	12.67	12.71	12.71	12.64	377,910
2018-11-20	12.68	12.67	12.68	12.64	427,780
2018-11-19	12.65	12.67	12.69	12.65	221,549
2018-11-16	12.62	12.65	12.66	12.62	439,205
2018-11-15	12.62	12.63	12.66	12.62	344,620
2018-11-14	12.62	12.64	12.65	12.62	188,697
2018-11-13	12.61	12.64	12.64	12.61	204,907
2018-11-12	12.60	12.60	12.62	12.59	516,613
2018-11-09	12.61	12.60	12.63	12.60	493,754
2018-11-08	12.60	12.61	12.62	12.59	370,929
2018-11-07	12.61	12.61	12.63	12.59	589,244
2018-11-06	12.59	12.60	12.61	12.59	441,204
2018-11-05	12.60	12.60	12.61	12.58	433,159
2018-11-02	12.63	12.59	12.63	12.58	608,770
2018-11-01	12.64	12.61	12.68	12.58	691,694
2018-10-31	12.62	12.65	12.66	12.60	533,319
2018-10-30	12.61	12.60	12.63	12.58	562,848
2018-10-29	12.63	12.61	12.67	12.57	503,741

Stock Information

Corium International Inc. Company Name:

CORI Stock Symbol:

NASDAQ Market:

Get CORI Alerts

News, Short Squeeze, Breakout and More Instantly...

CORI - Corium, Inc. Announces FDA Filing Acceptance of New Drug Application for ADLARITY® (donepezil transdermal system) for the Treatment of Alzheimer's Disease

MENLO PARK, Calif., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Corium, Inc., a commercial-stage biopharmaceutical company leading the development of novel transdermal healthcare products that are intended to provide alternative treatment options for patients and their families, today announced that ...
CORI - Corium Appoints Perry Sternberg as Chief Executive Officer

MENLO PARK, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Corium, Inc. announced today that its Board of Directors has named Perry Sternberg as Chief Executive Officer. Mr. Sternberg is a senior pharmaceutical executive with commercial experience across a wide range of therapeutic areas ...
CORI - Corium Announces Offer to Purchase for Cash Any and All of the $120,000,000 Aggregate Outstanding Principal Amount of 5.00% Convertible Senior Notes due 2025

MENLO PARK, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc., a Delaware corporation (“Corium”, the “Issuer”, “we”, “us” or “our”), today announced that, as a result of its acquisition by Gurnet Point ...